Patent Expiration

ZOMIG (zolmitriptan) Astrazeneca Patent: 7,220,767 Expiration: May 28, 2021 See More … For more information on how DrugPatentWatch can help […]

ZOMIG (zolmitriptan) Astrazeneca Patent: 7,220,767 Expiration: May 28, 2021 See More … For more information on how DrugPatentWatch can help

Annual Drug Patent Expirations for NICODERM+CQ Nicoderm Cq is a drug marketed by Sanofi Aventis Us and is included in

Annual Drug Patent Expirations for AMITIZA Amitiza is a drug marketed by Sucampo Pharma Llc and is included in one

Annual Drug Patent Expirations for FIRMAGON Firmagon is a drug marketed by Ferring and is included in one NDA. It

TECHNIVIE (ombitasvir; paritaprevir; ritonavir) Abbvie inc Patent: 7,364,752 Expiration: May 10, 2021 See More … For more information on how

Annual Drug Patent Expirations for ORAVERSE Oraverse is a drug marketed by Septodont Holding and is included in one NDA.

Annual Drug Patent Expirations for SUSTOL Sustol is a drug marketed by Heron Theraps Inc and is included in one

Annual Drug Patent Expirations for TECHNIVIE Technivie is a drug marketed by Abbvie Inc and is included in one NDA.